Abstract
Cyclosporine (CsA) is the first of a new order of pharmacological immune suppressants and represents a significant advance in the clinical control of graft rejection. In laboratory animals, its capacity to prolong allograft survival has been well documented, including reports of indefinite donor-specific immunological tolerance after shortterm CsA treatment. There is also evidence that CsA can inhibit the onset or progress of a variety of experimental autoimmune diseases. Underlying these properties of the drug is its capacity to selectively interfere with T helper cell activation and lymphokine production, although some direct effects on B cells have also been reported. In addition, sparing of suppressor cells may in part explain the mode of action of CsA which, at the molecular level, is not understood.
CsA-induced nephrotoxicity in the rat has been extensively studied and is characterized by reversible proximal tubular cell damage. This problem may be aggravated by concomitant administration of other potentially nephrotoxic drugs, such as gentamicin, or by therapeutic agents which interfere with the metabolism of CsA.
CsA is metabolized in the liver and excreted in the bile. Although the pathway of hepatic metabolism of CsA has not been precisely elucidated, animal studies suggest that agents capable of inducing metabolism of the drug CsA could be used to alleviate its nephrotoxic properties.
Similar content being viewed by others
References
S. Alberti, D. Boraschi, W. Luini andA. Tagliabue,Effects of in vivo treatments with cyclosporin A on mouse cell-mediated immune responses, Int. J. Immunopharmacol.3, 357–364 (1981).
P. Alexander, Cyclosporin A and the growth, dissemination and induction of tumours. InCyclosporin A, pp. 299–305 (Ed.D.J.G. White). Elsevier Biomedical Press, Amsterdam 1982.
L. Andrus andK.J. Lafferty,Inhibition of T cell activity by cyclosporin A, Scand. J. Immunol.15, 449–458 (1982).
D. Armerding, M. Scriba, A. Hren andH. Rossiter,Modulation by cyclosporin A of murine natural resistance against herpes simplex virus infection. I. Interference with the susceptibility to herpes simplex virus infection, Antiviral Research2, 3–11 (1982).
D. Armerding, M. Scriba, H. Kirchner, A. Hren andH. Rossiter,Modulation by cyclosporin A of murine natural resistance against herpes simplex virus infection. II. Influence on the HSV-induced natural killer cell responses, macrophage activities and interferon levels, Antiviral Research2, 13–26 (1982).
W.M. Baldwin, I.F. Hutchinson, C.J.L.M. Meijer andN.L. Tilney,Immune responses to organ allografts. III. Marked decrease in medullary thymocytes and splenic T lymphocytes after cyclosporin A treatment, Transplantation31, 117–120 (1981).
C.R. Baxter, G.G. Duggin, N.S. Willis, B.M. Hall, J.S. Horvath andD.J. Tiller,Cyclosporin A-induced increases in renin storage and release, Res. Comm. Chem. Pathol. Pharmacol.37, 305–311 (1982).
T.A.G. Bell, D.L. Easty andK.G. McCullagh,A placebo-controlled blind trial of cyclosporin A in prevention of corneal graft rejection in rabbits, Br. J. Ophthal.66, 303–308 (1982).
R. Berger, J.G. Meingassner andW. Knapp,In vitro effects of cyclosporin A on human B-cell responses, Scand. J. Immunol.17, 241–249 (1983).
G.A. Bird, S.M. McLachlan andS. Britton,Cyclosporin A promotes spontaneous outgrowth in vitro of Epstein-Barr virus induced B-cell lines, Nature289, 300–301 (1981).
J.T. Blair, A.W. Thomson, P.H. Whiting, R.J.L. Davidson andJ.G. Simpson,Toxicity of the immune suppressant cyclosporin A in the rat, J. Path.138, 163–178 (1982).
C. Bolton, G. Allsopp andM.L. Cuzner,The effect of cyclosporin A on the adoptive transfer of experimental allergic encephalomyelitis in the Lewis rat, Clin. exp. Immunol.47, 127–132 (1982).
C. Bolton, J.F. Borel, M.L. Cuzner, A.N. Davison andA.M. Turner, Autoimmunity: Cyclosporin A therapy in experimental allergic encephalomyelitis. InCyclosporin A, pp. 135–142. (Ed.D.J.G. White). Elsevier Biomedical Press, Amsterdam 1982.
C. Bolton andM.L. Cuzner, Modification of EAE by nonsteroidal anti-inflammatory drugs. InThe Suppression of Experimental Allergic Ecephalomyelitis and Multiple Sclerosis, p. 189. (EdsA.N. Davison andM.L. Cuzner). Academic Press, London 1980.
J. Bordes-Aznar, P.A. Lear, T.B. Strom, N.L. Tilney andJ.W. Kupiec-Weglinski,Kinetics of cyclosporin A-induced unresponsiveness to cardiac allografts in rats, Transplant. Proc.15, 500–503 (1983).
J.F. Borel,Cyclosporin A, Triangle20, 97–105 (1981).
J.F. Borel, C. Feurer, H.U. Gubler andH. Stähelin,Biological effects of cyclosporin A: a new antilymphocytic agent, Agents and Actions6, 468–475 (1976).
J.F. Borel, C. Feurer, C. Magnée andH. Stähelin,Effects of the new anti-lymphocytic peptide cyclosporin A in animals, Immunology32, 1017–1025 (1977).
J.F. Borel andJ. Meszaros,Skin transplantation in mice and dogs-effect of cyclosporin A and dihydrocyclosporin C, Transplantation29, 161–162 (1980).
J.F. Borel andD. Wiesinger, Effect of cyclosporin A on murine lymphoid cells. InRegulatory Mechanisms in Lymphocyte Activation. Proceedings of the 11th Leukocyte Culture Conference, p. 716 (Ed.D. O. Lucas). Academic Press, New York 1977.
J.C.C. Borleffs, Z. de By-Aghai andR.L. Marquet,Beneficial influence of cyclosporin A and standard immunosuppression on kidney graft survival in transfused rhesus monkeys, Transplantation32, 161–162 (1981).
J.C.C. Borleffs, P. Neuhaus, R.L. Marquet, C. Zurcher andH. Balner, Cyclosporin A and kidney transplantation in rhesus monkeys. InCyclosporin A, pp. 329–342. (Ed.D.J.G. White). Elsevier Biomedical Press, Amsterdam 1982.
S. Britton andR. Palacios,Cyclosporin A — usefulness, risks and mechanism of action, Immunol. Rev.65, 5–22 (1982).
D. Bunjes, C. Hardt, M. Röllinghoff andH. Wagner,Cyclosporin A Mediates Immunosuppression of Primary Cytotoxic T Cell Responses by Impairing the Release of Interleukin 1 and Interleukin 2, Eur. J. Immunol.11, 657–661 (1981).
J. Burckhardt andB. Guggenheim,Cyclosporin A: in vivo and in vitro suppression of rat T-lymphocyte function, Immunology36, 753–757 (1979).
R.Y. Calne, K. Rolles, D.J.G. White, S. Thiru, D.B. Evans, P. McMaster, D.C. Dunn, G.N. Craddock, R.G. Henderson, S. Aziz andP. Lewis,Cyclosporin A initially as the only immuno-suppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases and 2 livers, Lancet2, 1033–1036 (1979).
R.Y. Calne andD.J.G. White,Cyclosporin A — a powerful immunosuppressant in dogs with renal allografts, IRCS Med. Sci.5, 595 (1977).
R.Y. Calne, D.J.G. White, D.B. Evans, S. Thiru, R.G. Henderson, D.V. Hamilton, K. Rolles, P. McMaster, T.J. Duffy, B.R.D. MacDougall andR. Williams,Cyclosporin A in cadaveric organ transplantation, Br. med. J.282, 934–936 (1981).
R.Y. Calne, D.J.G. White, B.D. Pentlow, K. Rolles, T. Syrakos, T. Ohtawa, D.P. Smith, P. McMaster, D.B. Evans, B.M. Herbertson, andS. Thiru,Cyclosporin A: preliminary observations in dogs with pancreatic duodenal allografts and patients with cadaveric renal transplants, Transplant. Proc.11, 860–864 (1979).
R.Y. Calne, D.J.G. White, K. Rolles, D.P. Smith andB.M. Herbertson,Prolonged survival of pig orthotopic heart grafts treated with cyclosporin A, Lancet 1, 1183–1185 (1978).
S. Cammisuli, The effect of cyclosporin A on cell interactions within the immune system. In:Cyclosporin A, pp. 243–259. (Ed.D.J.G. White). Elsevier Biomedical Press, Amsterdam 1982.
K.O. Cox, A.C. Allison andB. Samcewicz,Experimental erythrocyte autoimmunity prevented by suppressor T cells in mice treated with cyclosporin A, Clin. Immunol. Immunopathol.28, 90–95 (1983).
C. Cunningham, P.H. Whiting, M.D. Burke, D.N. Wheatley andJ.G. Simpson,Increasing the hepatic metabolism of cyclosporine abolishes nephrotoxicity, Transplant. Proc.15, Suppl. 1, 2712–2715 (1983).
H.J. Deeg, R.C. Hackman, P.L. Weiden andR. Storb,Growth of canine tumors transplanted into normal adult dogs immunosuppressed by cyclosporin A, Cancer Immunol. & Immunother.12, 147–152 (1982).
H.J. Deeg, R. Storb, L. Gerhard-Miller, H.M. Shulman, P.L. Weiden andE.D. Thomas,Cyclosporin A, a powerful immunosuppressant in vivo and in vitro in the dog, fails to induce tolerance, Transplantation29, 230–235 (1980).
H.J. Deeg, R. Storb, P.L. Weiden, T. Graham, K. Atkinson andE.D. Thomas,Cyclosporin A: effect on marrow engraftment and graft-versus-host disease in dogs, Transplant. Proc.13, 402–405 (1981).
S. Denham, J.M. Styles, R.K. Barfoot andC.J. Dean,Reversible suppression of allo-antibody production by cyclosporin A, Int. Archs Allergy appl. Immun.62, 453–458 (1980).
H. Dieperink, H. Starklint andP.C. Leyssac,Nephrotoxicity of cyclosporine — an animal model, Transplant. Proc.15, Suppl. 1, 2736–2741 (1983).
D.W. Dongworth andG.G.B. Klaus,Effects of cyclosporin A on the immune system of the mouse, Eur. J. Immunol.12, 1018–1022 (1982).
D.C. Dunn, D.J.G. White, B.M. Herbertson andJ. Wade,Prolongation of kidney survival during and after cyclosporin A therapy, Transplantation27, 359–361 (1979).
D.F. Du Toit, H. Reece-Smith, P. McShane, T. Denton andP.J. Morris,Effect of cyclosporin A on allotransplanted pancreatic fragments to the spleen of totally pancreatectomized dogs, Transplantation33, 302–307 (1982).
S.A. Eccles, S.E. Heckford andP. Alexander,Effect of cyclosporin A on the growth and spontaneous metastasis of syngeneic animal tumours, Br. J. Cancer42, 252–259 (1980).
M.J.G. Farthing, M.L. Clark, A. Pendry, J. Sloane andP. Alexander,Nature of the toxicity of cyclosporin A in the rat, Biochem. Pharmac.30, 3311–3316 (1981).
R.M. Ferguson, D.E.R. Sutherland, R.L. Simmons andJ.S. Najarian,Ketoconazole, cyclosporin metabolism and renal transplantation, Lancet 2, 882–883 (1982).
R.K. Fidelus, R.M. Ferguson, M.B. Widmer, S.-L. Wee, F.H. Bach andC.G. Orosz,Effect of cyclosporin A on murine and human T helper cell clones, Transplantation34, 308–311 (1982).
R. Foa andD. Catovsky,Inhibitory effect of cyclosporin A on peripheral blood and bone marrow T lymphocyte colony formation, Clin. exp. Immunol.45, 371–375 (1981).
J.F.W. Garvey, P. McShane, M.D. Poole, P.R. Millard andP.J. Morris,The effect of cyclosporin A on experimental pancreas allografts in the rat, Transplant. Proc.12, 266–269 (1980).
M.Y. Gordon andJ.W. Singer,Selective effects of cyclosporin A on colony-forming lymphoid and myeloid cells in man, Nature, Lond.279, 433–434 (1979).
A. Gratwohl, K. Forster andB. Speck,Skin grafts in rabbits with cyclosporin A; absence of induction of tolerance and untoward side effects, Transplantation31, 136–138 (1981).
A. Gratwohl, I. Forster andB. Speck,Histioincompatible skin and marrow grafts in rabbits on cyclosporin A, Transplantation33, 361–364 (1982).
A. Gratwohl, B. Speck, M. Wenk, I. Forster, M. Müller, B. Osterwalder, C. Nissen, andF. Follath,Cyclosporin in human bone marrow transplantation; serum concentration, graft-versus-host disease and nephrotoxicity, Transplantation36, 40–44 (1983).
C.J. Green andA.C. Allison,Extensive prolongation of rabbit kidney allograft survival after short-term cyclosporin A treatment, Lancet1, 1182–1183 (1978).
C.J. Green, A.C. Allison andS. Precious,Induction of specific tolerance in rabbits by kidney allografting and short periods of cyclosporin A treatment, Lancet2, 123–125 (1979).
C.J. Green, G. Grimaldi, S. Simpkin andA. Johnson, Immunosuppression of rabbit ovarian and adnexal allografts with cyclosporin A. InCyclosporin A, pp. 165–171. (Ed.D.J.G. White). Elsevier Biomedical Press, Amsterdam Press, Amsterdam, 1982.
C.J. Green, E. Kemp, G. Kemp, S. Larsen, H. Starklint andS. Simpkin, Prolongation of concordant renal xenografts in rabbit recipients by a short course of cyclosporin A treatment. InCyclosporin A, pp. 155–163. (Ed.D.J.G. White). Elsevier Biomedical Press, Amsterdam 1982.
B.M. Hall, M.E. Jelbart andS.E. Dorsch,Alloreactivity in rats treated with cyclosporin A to prolong cardiac graft survival, Transplant. Proc.15, 504–507 (1983).
D.V. Hamilton, D.B. Evans andS. Thiru, Toxicity of cyclosporin in organ grafting. InCyclosporin A, pp. 393–411. (Ed.D.J.G. White). Elsevier Biomedical Press, Amsterdam 1982.
P. Häyry, J. Ahonen, E. von Willebrand, B. Eklund, K. Höckekstedt, A. Kauste, E. Taskinen, I. Lautenschlager, M. Lalla andH. Sarelin,Effect of cyclosporin A on the in situ inflammatory response of human renal allograft rejection. A preliminary report, Scand. J. Immunol.16, 135–149 (1982).
P. Häyry andT. Paavonen,Effect of cyclosporin A on T-dependent and T-independent immunoglobulin synthesis in vitro, Nature, Lond.287, 542–544 (1980).
B. Hermann andW. Mueller,Die Therapie der Chronischen Polyarthritis mit Cyclosporin A, Einen Neuen Immunosuppressivum, Akt. Rheumatol.,4, 173–183 (1979).
A.D. Hess, A.D. Donnenberg, P.J. Tutschka andG.W. Santos,Effect of cyclosporin A on human lymphocyte responses in vitro. V. Analysis of responding T lymphocyte subpopulations in primary MLR with monoclonal antibodies, J. Immun.130, 717–721 (1983).
A.D. Hess andP.J. Tutschka, itEffect of cyclosporin A on human lymphocyte responses in vitro. I. CsA allows for the expression of alloantigen-activated suppressor cells while preferentially inhibiting the induction of cytolytic effector lymphocytes in MLR. J. Immun.124, 2601–2608.
A.D. Hess, P.J. Tutschka, Z. Pu andG.W. Santos,Effect of cyclosporin A on human lymphocyte responses in vitro. IV. Production of T cell stimulatory growth factors and development of responsiveness to these growth factors in CsA-treated primary MLR cultures, J. Immun.128, 360–367 (1982).
A.D. Hess, P.J. Tutschka andG.W. Santos,Effect of cyclosporin A on human lymphocytes in vitro. II. Induction of specific alloantigen unresponsiveness mediated by a nylon wool adherent suppressor cell, J. Immun.126, 961–968 (1981).
A.D. Hess, P.J. Tutschka andG.W. Santos,Effect of cyclosporin A on human lymphocyte responses in vitro. III. CsA inhibits the production of T lymphocyte growth factors in secondary mixed lymphocyte responses but does not inhibit the response of primed lymphocytes to TCGF, J. Immun.128, 355–359 (1982).
C.W. Hewitt, K.S. Black, L.A. Fraser, J.G. Osborne, T.J. Sayles, B.M. Achauer, D.C. Martin andD.W. Furnas,Cyclosporin A (CyA) is superior to prior donor-specific blood (DSB) transfusion for the extensive prolongation of rat limb allograft survival, Transplant. Proc.15, 514–517 (1983).
W.P. Homan, J.W. Fabre, M.E. French, P.R. Millard, T.G. Denton andP.J. Morris,Reversal of acute rejection episodes by cyclosporin A in dogs receiving renal allografts, Transplantation29, 262–263 (1980).
W.P. Homan, J.W. Fabre, P.R. Millard andP.J. Morris,Effect of cyclosporin A upon second-set rejection of rat renal allografts, Transplantation30, 354–357 (1980).
W.P. Homan, J.W. Fabre andP.J. Morris,Nature of the unresponsiveness induced by cyclosporin A in rats bearing renal allografts, Transplantation28, 439–441 (1979).
W.P. Homan, J.W. Fabre, K.A. Williams, P.R. Millard andP.J. Morris,Studies on the immunosuppressive properties of cyclosporin A in rats receiving renal allografts, Transplantation29, 361–366 (1980).
W.P. Homan, K.A. Williams, J.W. Fabre, P.R. Millard andP.J. Morris,Prolongation of cardiac zenograft survival in rats receiving cyclosporin A, Transplantation31, 164–166 (1980).
W.P. Homan, K.A. Williams, P.R. Millard andP.J. Morris,Prolongation of renal allograft survival in the rat by pretreatment with donor antigen and cyclosporin A, Transplantation31, 423–427 (1981).
T. Horsburgh, P. Wood andL. Brent,Suppression of in vitro lymphocyte reactivity by cyclosporin A: existence of a population of drug-resistant cytotoxic lymphocytes, Nature286, 609–611 (1980).
J. Hows, R. Harris, S. Palmer andE.C. Gordon-Smith,Immunosuppression with cyclosporin A in allogeneic bone marrow transplantation for severe aplastic anaemia: preliminary studies, Br. J. Haemat.48, 227–236 (1981).
W.T. Hughes andB. Smith,Provocation of infection due to Pneumocystis-carinii by cyclosporin A, J. Infect. Dis.145, 767 (1982).
P.A. Hunter, A. Garner, K.R. Wilhelmus, N.S.C. Rice andB.R. Jones,Corneal graft rejection—a new rabbit model and cyclosporin A, Br. J. Ophthal.66, 292–302 (1982).
I.F. Hutchinson, C.A. Shadur, J.S.A. Duarte, T.B. Strom andN.L. Tilney,Cyclosporin A spares selectively lymphocytes with donor-specific suppressor characteristics, Transplantation32, 210–216 (1981).
M. Introna, P. Allavena, F. Spreafico andA. Mantovani,Inhibition of human natural killer activity by cyclosporin A, Transplantation31, 113–116 (1981).
D.A. Isenberg, M.L. Snaith, W.J.W. Morrow, A.A. Al-Khader, S.L. Cohen, C. Fisher andJ. Mowbray,Cyclosporin A for the treatment of systemic lupus erythematosus, Int. J. Immunopharmacol.3, 163–169 (1981).
S.W. Jamieson, N.A. Burton, C.P. Bieber, B.A., Reitz, P.E. Oyer, E.E. Stinson andN.E. Shumway,Cardiac allograft survival in primates treated with cyclosporin A, Lancet1, 545 (1979).
R.L. Janco andD. English,Cyclosporine and human neutrophil function, Transplantation35, 501–503 (1983).
B.D. Kahan, C.T. Van Buren, S.N. Lin, Y. Ono, G. Agostino, S.J. Legrue, M. Boileau W.D. Payne andR.H. Kerman,Immunopharmacological monitoring of cyclosporin A-treated recipients of cadaveric kidney allografts, Transplantation34, 36–45 (1982).
V.V. Kalman andG.R. Klimpel,Cyclosporin A inhibits the production of gamma interferon (IFN γ) but does not inhibit production of virus-induced IFN α/β, Cell. Immunol.78, 122–129 (1983).
K. Kawahara, D.E.R. Sutherland, J. Rynasiewicz andJ.S. Najarian,Prolongation of heterotopic cardiac allografts in rats by cyclosporin A, Surgery88, 594–600 (1980).
J.E. Kay andC.R. Benzie,Effects of cyclosporin A on the metabolism of unstimulated and mitogen-activated lymphocytes, Immunology49, 153–160 (1983).
P.A. Keown, C.R. Stiller, R.A. Ulan, N.R. Sinclair, W.J. Wall, G. Carruthers andW. Howson,Immunological and pharmacological monitoring in the clinical use of cyclosporin A, Lancet1, 686–689 (1981).
G.G.B. Klaus andA. Kunkl,Effects of cyclosporine in the immune system of the mouse. II. Cyclosporine inhibits the effector function of primary T helper cells, but not helper cell priming, Transplantation36, 80–84 (1983).
M. Koponen, A. Grieder andF. Loor,The effects of cyclosporins on the cell cycle of T-lymphoid cell lines, Expl Cell Res.140, 237–250 (1982).
A.J. Kostakis, D.J.G. White andR.Y. Calne,Prolongation of rat heart allograft survival by cyclosporin A, IRCS Med. Sci.5, 280 (1977).
W. Kreis andA. Soricelli,Cyclosporins: immunosuppressive agents with antitumor activity, Experientia35, 1506–1508 (1979).
A. Kunkl andG.G.B. Klaus,Selective effects of cyclosporin A on functional B cell subsets in the mouse, J. Immun.125, 2526–2531 (1980).
J.W. Kupiec-Weglinski, P.A. Lear, J. Bordes-Aznar, N.L. Tilney andT.B. Strom,Acute rejection in cyclosporin A-treated graft recipients occurs following abrogation of suppressor cells, Transplant. Proc.15, 531–534 (1983).
J.B. Kurtz andW.P. Homan,Murine cytomegalovirus infection and cyclosporin A, Transplantation34, 215–216 (1982).
U. Landegren, V. Ramstedt, I. Axberg, A. Örn andH. Wigzell,Cyclosporin A permits the distinction between specific T and NK activity generated in a human MLC, Int. J. Cancer28, 725–730 (1981).
E.-L. Larrson,Cyclosporin A and dexamethasone suppress T cell responses by selectively acting at distinct sites of the triggering process, J. Immun.124, 2828–2833 (1980).
A. Laupacis, C.R. Stiller, C. Gardell, P. Keown, J. Dupre, A.C. Wallace andP. Thibert,Cyclosporin prevents diabetes in BB Wistar rats, Lancet1, 10–12 (1983).
S.B. Leapman, R.S. Filo, E.J. Smith andP.G. Smith,Differential effects of cyclosporin A on lymphocyte sub-populations, Transplant. Proc.13, 405 (1981).
S.P.M. Lems, P.J.A. Capel andR.A.P. Koene,Prolongation of mouse skin allograft survival by cyclosporin A. Graft rejection after withdrawal of therapy, Transplant. Proc.12, 283–286 (1980).
P. Leoni, R.C. Garcia andA.C. Allison,Effects of cyclosporin A on human lymphocytes in culture, J. Clin. Lab. Immunol.1, 67–72 (1978).
A.A. Like, M. Anthony, D.L. Guberski andA.A. Rossini,Spontaneous diabetes mellitus in the BB/W rat. Effects of glucocorticoids, cyclosporin A and antiserum to rat lymphocytes, Diabetes32, 326–330 (1983).
N.J. Lindsay, K.R. Harris, H.B. Norman, J.L. Smith, H.A. Lee andM. Slapek,The effect of cyclosporin A on the primary and secondary immune responses in the rabbit, Transplant. Proc.12, 252–255 (1980).
K.G. Lurie, M.E. Billingham, S.W. Jamieson, D.C. Harrison andB.A. Reitz,Pathogenesis and prevention of graft arteriosclerosis in an experimental heart transplant model, Transplantation31, 41–47 (1981).
J.R. Markwick, J.D. Chambers, J.R. Hobbs andG.D. Pegrum,Timing of cyclosporin A therapy for absorption of HVG and GVH responses in rats, Lancet2, 1037 (1979).
B.E. Matter, P. Donatsch, R.R. Racine, B. Schmid andW. Suter,Genotoxicity evaluation of cyclosporin A, a new immuno-suppressive agent, Mutation Research105, 257–264 (1982).
G. Maurer, B. Keller andH.R. Loosli,3H-OL 27-400: Isolation and Structure Elucidation of its Metabolites, Document, Sandoz Ltd., Basle (1981).
A.M. McGregor, D.P. Rennie, A.P. Weetman, R.A. Hassman, S.M. Foord, C. Dieguez andR. Hall,The influence of cyclosporin A on experimental autoimmune disease in the rat, Life Sci.32, 97–108 (1983).
L.C. McIntosh andA.W. Thomson,Activity of the mononuclear phagocyte system in cyclosporin A treated mice, Transplantation30, 384–386 (1980).
F.N. McKenzie, C.R. Stiller, W.J. Wall, P. Keown, M.D. Silver, A. Painvin andR.O. Heimbecker,Studies of canine heterotopic heart allografts treated with cyclosporin A, Transplant. Proc.15, 1244–1246 (1983).
M.J. Mihatsch, W. Olivieri, I. Marret, G. Thiel, F. Harder andH.U. Zollinger,Giant mitochondria in renal tubular cells and cyclosporin A, Lancet1, 1162–1163 (1981).
P.J. Morris,Cyclosporin A, Transplantation32, 349–354 (1981).
P.J. Morris, D.R. Finch, J.F. Garvey, M.D. Poole andP.R. Millard,Suppression of rejection of allogeneic islet tissue in the rat, Diabetes29, 107 (1981).
A. Muraguchi, J.L. Butler, J.H. Kehrl, R.J.M. Falkoff andA.C. Fauci,Selective suppression of an early step in human B cell activation by cyclosporin A, J. exp. Med.158, 690–702 (1983).
T. Nagao, D.J.G. White andR.Y. Calne,Kinetics of unresponsiveness induced by a short course of cyclosporin A, Transplantation33, 31–35 (1982).
A. Nemlander, A. Soots, E. Von Willebrand, G. Tallqvist andP. Häyry,Effect of cyclosporin A on the in situ inflammatory response of rat renal allograft rejection, Scand. J. Immunol.16, 91–102 (1982).
W. Niederberger, M. Lemaire, K. Nussbaumer, G. Maurer andO. Wagner,Distribution of cyclosporine in blood components and tissues, Transplant. Proc. Suppl. In Press (1983).
A.J. Norin, E.E. Emeson andF.J. Veith,Unresponsiveness to lung allografts in mongrel dogs after cessation of cyclosporin A therapy, Transplant. Proc.15, 508–510 (1983).
A.J. Norin, F.J. Veith, E.E. Emeson, C.M. Montefusco, K.L. Pinsker andS.L. Kamholz,Improved survival of transplanted lungs in mongrel dogs treated with cyclosporin A, Transplantation32, 259–260 (1981).
J.S. Nowak, O. Kai, R. Peck andR.M. Franklin,The effects of cyclosporin A on the chicken immune system, Eur. J. Immunol.12, 867–876 (1982).
R.B. Nussenblatt, A.G. Palestine, A.H. Rook, I. Scher, W.B. Wacker andI. Gery,Treatment of intraocular inflammatory disease with cyclosporin A, Lancet2, 235–238 (1983).
R.B. Nussenblatt, M.M. Rodrigues, M.C. Salinas-Carmona, I. Gery, S. Cevario andW. Wacker,Modulation of experimental autoimmune uveitis with cyclosporin A, Archs. Ophthal.100, 1146–1149 (1982).
R.B. Nussenblatt, M.M. Rodrigues, W.B. Wacker, S.J. Cevario, M.C. Salinas-Carmona andI. Gery,Cyclosporin A. Inhibition of experimental autoimmune uveitis in Lewis rats, J. clin. Invest.67, 1228–1231 (1981).
C.G. Orosz, R.K. Fidelus, D.C. Roopenian, M.B. Widmer, R.M. Ferguson andF.H. Bach,Analysis of cloned T cell function. I. Discussion of cloned T cell proliferative responses using cyclosporin A, J. Immun.129, 1865–1868. (1982).
T. Paavonen, H. Järveläinen, S. Kontiainen andP. Häyry,Effect of cyclosporin A on in vitro proliferative activity and immunoglobulin synthesis of isolated human lymphoid cell subpopulations, Clin. exp. Immunol.43, 342–350 (1981).
R. Palacios,Cyclosporin A inhibits the proliferative response and the generation of helper, suppressor and cytotoxic T-cell functions in the autologous mixed lymphocyte reaction, Cell. Immunol.61, 453–462 (1981).
R. Palacios,Cyclosporin A abrogates proliferation of T cells and generation of suppressor and cytotoxic T-cell function induced by Epstein-Barr virus, Immunobiology160, 321–329 (1981).
R. Palacios,Concanavalin A triggers T lymphocytes by directly interacting with their receptors for activation, J. Immun.128, 337–342 (1982).
R. Palacios andG. Möller,Cyclosporin A blocks receptors for HLA-DR antigens on T cells, Nature290, 792–794 (1981).
D. Parker, K. Drössler andJ.L. Turk,Kinetics of the effect of a single dose of cyclosporin A on antibody and cell-mediated immune responses in the guinea pig, Int. J. Immunopharmac6, 67–74 (1984).
A. Pendry andP. Alexander, Stimulation of hair growth on nude mice by cyclosporin A. InCyclosporin A pp. 77–81. (Ed.D.J.G. White). Elsevier Biomedical Press, Amsterdam 1982.
J.L. Pennock, B.A. Reitz, C.P. Bieber, A. Aziz, P.E. Oyer, S. Strober, R. Hoppe, H.S. Kaplan, E.B. Stinson andN.E. Shumway,Survival of primates following orthotopic cardiac transplantation treated with total lymphoid irradiation and chemical immune suppression, Transplantation32, 467–473 (1981).
J.L. Pennock, B.A. Reitz, C.P. Bieber, S.W. Jamieson, N.A. Burton, A.A. Raney, P.E. Oyer andE.B. Stinson,Lethal complications due to cyclosporin A immune suppression with combination drug and combined heart and lung transplantation, Surg. Forum31, 375–378 (1980).
T.J. Petcher, H.P. Weber andA. Rüegger,Crystal and molecular structure of an iodo-derivative of the cyclic undecapeptide cyclosporin A, Helv. chim. Acta59, 1480–1488 (1976).
R.L. Powles, H.M. Clink, D. Spence, G. Morgenstern, J.G. Watson, P.J. Selby, M. Woods, A. Barrett, B. Jameson, J. Sloane, S.D. Lawler, H.E.M. Kay, D. Lawson, T.J. McElwain andP. Alexander,Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone marrow transplantation, Lancet1, 327–329 (1980).
Preliminary Results of a European Multicentre Trial,Cyclosporin A as sole immunosuppressive agent in recipients of kidney allografts from cadaver donors, Lancetii, 57–60 (1982).
A. Procyshyn, P. McMaster, R.Y. Calne, R. Valdes andK. Rolles,Successful prolongation of canine pancreas allografts with cyclosporin A, Br. J. Surg.66, 907 (1979).
J. Prop, H.L. Bartels, A.H. Petersen, C.R.H. Wildevuur andP. Nieuwenhuis,A single injection of cyclopsorin A reverses lung allograft rejection in the rat, Transplant. Proc.15, 511–513 (1983).
H. Reece-Smith, D.F. Du Toit, P. McShane andP.J. Morris,Effect of cyclosporin A on rejection of pancreatic islets transplanted under the renal capsule, Transplantation32, 333–334 (1981).
H. Reece-Smith, W.P. Homan, D.F. Du Toit, P. McShane andP.J. Morris A technique for transplanting pancreatic islets as a vascularized graft and prevention of rejection with cyclosporin A, Transplantation31, 442–444 (1981).
B.A. Reitz, C.P. Bieber andJ.L. Pennock, Cyclosporin A and lymphoma in non-human primates. InCyclosporin A, pp. 317–328. (Ed.D.J.G. White). Elsevier Biomedical Press, Amsterdam 1982.
G. Routheier, O. Epstein, G. Janossy, H.C. Thomas, S. Sherlock, P.C. Kung andG. Goldstein,Effects of cyclosporin A on suppressor and inducer T lymphocytes in primary biliary cirrhosis, Lancet2, 1223–1226 (1980).
B. Ryffel, Experimental toxicological studies with cyclosporin A. InCyclosporin A, pp. 45–75. (Ed.D.J.G. White). Elsevier Biomedical Press, Amsterdam 1982.
B. Ryffel, H. Deyssenroth andJ.F. Borel, Cyclosporin A: effects on the mouse thymus, Agents and Actions11, 373–379 (1981).
B. Ryffel, P. Donatsch, M. Madörin, B.E. Matter, G. Rüttimann, H. Schön, R. Stoll andJ. Wilson,Toxicological evaluation of cyclosporin A, Arch. Toxicol.53, 107–141 (1983).
J.J. Rynasiewicz, D.E.R. Sutherland, K. Kawahara, P. Gorecki andJ.S. Najarian,Cyclosporin A prolongation of segmental pancreatic and islet allograft function in rats, Transplant. Proc.12, 270–274 (1980).
C. Shao-Hsien, I. Lang, H. Gunn andP. Lydyard,Effect of in vitro cyclosporin A treatment on human natural and antibody-dependent cell-mediated cytotoxicity, Transplantation35, 127–129 (1983).
W.F.I. Shepherd, D.J. Coster, T. Chin Fook, N.S.C. Rice andB.R. Jones,Effect of cyclosporin A on the survival of corneal grafts in rabbits, Br. J. Ophthal.64, 148–153 (1980).
H. Siegl, R. Petric andB. Ryffel,Effects of cyclosporine on renin-angiotensin-aldosterone, Transplant. Proc.15, Suppl. 1, 2719–2725 (1983).
H. Siegl andB. Ryffel,Effect of cyclosporin on renin-angiotensin-aldosterone system, Lancet2, 1274 (1982).
M.H. Simms, J.K. Cruickshank, J.D. Blainey, A.H. Cameron andA.D. Barnes,Effects of cyclosporin A in rat kidney grafts, Transplant. Proc.12, 256–260 (1980).
J.G. Simpson, J.T. Blair, P.H. Whiting andA.W. Thomson,Cyclosporin A-induced renal proximal tubular damage, IRCS Med. Sci.9, 562–563 (1981).
G.N. Smith,The effect of cyclosporin A on the primary immune response to allogeneic red cells in rabbits, Immunology45, 163–167 (1982).
T.E. Starzl, R. Weil, S. Iwatsuki, G. Klintmalm, G.P.J. Schrõter, L.J. Koep, Y. Iwaki, P.E. Terasaki andK.A. Porter,The use of cyclosporin A and prednisone in cadaver kidney transplantation, Surgery Gynec. Obstet.151, 17–26 (1980).
P. Sweny andN. Tidman,The effect of cyclosporin A on peripheral blood T cell subpopulations in renal allografts, Clin. exp. Immunol.47, 445–448 (1982).
A.W. Thomson, D.K. Moon, C.L. Geczy andD.S. Nelson,Cyclosporin A and lymphokines affecting macrophage behaviour, Transplant. Proc.15, Suppl. 1, 2390–2393 (1983).
A.W. Thomson, D.K. Moon, C.L. Geczy andD.S. Nelson,Cyclosporin A inhibits lymphokine production but not the responses of macrophages to lymphokines, Immunology48, 291–299 (1983).
A.W. Thomson, D.K. Moon, Y. Inoue, C.L. Geczy andD.S. Nelson,Modification of delayed-type hypersensitivity reactions to ovalbumin in cyclosporin A-treated guinea pigs, Immunology48, 301–308 (1983).
A.W. Thomson, D.K. Moon andD.S. Nelson,Inhibition of delayed-type hypersensitivity reactions and lymphokine production by cyclosporin A in the mouse, Clin. exp. Immunol.52, 599–606 (1983).
A.W. Thomson, P.H. Whiting, J.T. Blair, R.J.L. Davidson andJ.G. Simpson,Pathological changes developing in the rat during a 3-week course of high dosage cyclosporin A and their reversal following drug withdrawal, Transplantation32, 271–277 (1981).
A.W. Thomson, P.H. Whiting, I.D. Cameron, S.E. Lessels andJ.G. Simpson,A toxicological study in rats receiving immunotherapeutic doses of cyclosporin A, Transplantation31, 121–124 (1981).
A.W. Thomson, P.H. Whiting andJ.G. Simpson, Pathobiology of cyclosporin A in experimental animals. InCyclosporin A, pp. 177–190. (EdD.J.G. White). Elsevier Biomedical Press, Amsterdam 1982.
C. Tomkins, R.H.M. King andP.K. Thomas,Modification of expeerimental allergic neuritis by cyclosporin A, Neuropathol. Appl. Neurobiol.6, 240 (1980).
G. Tosato, S.E. Pike, I.R. Koski andR.M. Blaese,Selective inhibition of immunoregulatory cell functions by cyclosporin A, J. Immun.128, 1986–1991 (1982).
P.J. Tutschka, W.E. Beschorner, A.C. Allison, W.H. Burns andG.W. Santos,Use of cyclosporin A in allogeneic bone marrow transplantation (BMT) in the rat, Nature280, 148–151 (1979).
D.W. Van Bekkum, S. Knaan andC. Zurcher,Effects of cyclosporin A on experimental graft-versus-host disease (GVHD) in rodents, Transplant. Proc.12, 278–282 (1980).
F.J. Veith, A.J. Norin, C.M. Montefusco, K.L. Pinsker, S.L. Kamholz, M.L. Gliedman andE. Emeson,Cyclosporin A in experimental lung transplantation, Transplantation32, 474–481 (1981).
B. Vialettes, M.C. Simon, V. Lassmann andP.H. Vague,Prolonged survival of allotransplanted islets of Langerhans after cyclosporin A treatment in rats, Transplantation28, 435–436 (1979).
A.O. Vladutiu,Effect of cyclosporine on experimental autoimmune thyroiditis in mice, Transplantation35, 518–520 (1983).
E. Von Willerbrand andP. Häyry,Cyclosporin A deposits in renal allografts, Lancet2, 189–192 (1983).
H. Wagner,Cyclosporin A: mechanism of action, Transplant. Proc.15, 523–526 (1983).
O. Wagner, Absorption and Excretion of3H-OL 27-400 (Drink Solution) in dogs, Document, Sandoz Ltd., Basle (1981).
J. Wallwork, C.G.A., McGregor, F.C. Wells, R. Cory-Pearce andT.A.H. English,Cyclosporin and intravenous sulphadimidine and trimethoprim therapy, Lancet1, 366–367 (1983).
B.S. Wang, E.H. Heacock, K.H. Collins, I.F. Hutchinson, N.L. Tilney andJ.A. Mannick,Suppressive effects of cyclosporin A on the induction of alloreactivity in vitro and in vivo, J. Immun.127, 89–93 (1981).
D.J. Watt, T.A. Partridge andJ.C. Sloper,Cyclosporin A as a means of preventing rejection of skeletal muscle allografts in mice, Transplantation31, 266–271 (1981).
R. Wenger, Chemistry of cyclosporin. InCyclosporin A, pp. 19–34. (Ed.D.J.G. White). Elsevier Biomedical Press, Amsterdam 1982.
D.J.G. White, A.M. Plumb, G. Pawelec andG. Brons,Cyclosporin A: an immunosuppressive agent preferentially active against proliferating T cells, Transplantation27, 55–58 (1979).
D.J.G. White, K. Rolles, T. Ottawa andO. Turell,Cyclosporin A induced long-term survival of fully incompatible skin and heart grafts in rats, Transplant. Proc.12, 261–265 (1980).
P.H. Whiting, C. Cunningham, A.W. Thomson andJ.G. Simpson,Enhancement of high dose cyclosporin A toxicity by frusemide, Biochem. Pharmac.33, 1075–1079 (1984).
P.H. Whiting andJ.G. Simpson,The enhancement of cyclosporin A-induced nephrotoxicity by gentamicin, Biochem. Pharmac.32, 2025–2028 (1983).
P.H. Whiting, J.G. Simpson, R.J.L. Davidson andA.W. Thomson,The toxic effects of combined administration of cyclosporin A and gentamicin, Br. J. exp. Path.63, 554–561 (1982).
P.H. Whiting, J.G. Simpson, R.J.L. Davidson andA.W. Thomson,Pathological changes in rats receiving cyclosporin A at immunotherapeutic dosage for 7 weeks, Br. J. exp. Path.64, 437–444 (1983).
P.H. Whiting, A.W. Thomson, J.T. Blair andJ.G. Simpson,Experimental cyclosporin A nephrotoxicity, Br. J. exp. Path.63, 88–94 (1982).
P.H. Whiting, A.W. Thomson andJ.G. Simpson,Renal and hepatic function in rats treated with gentamicin or cephalosporin antibiotics, Br. J. exp. Path.64, 693–701 (1983).
G. Wick, P.-U. Müller andS. Schwarz,Effect of cyclosporin A on spontaneous autoimmune thyroiditis of obese strain (OS) chickens, Eur. J. Immunol.12, 877–881 (1982).
R.H. Yanagihara andW.H. Adler,Inhibition of mouse natural killer activity by cyclosporin A, Immunology45, 325–332 (1982).
A.A. Zalewski andA.K. Gulati,Survival of nerve and Schwann cells in allografts after cyclosporin A treatment, Expl Neurol.70, 219–225 (1980).
F.A. Zimmerman, D.J.G. White, R. Grantzow, H.G. Dietz, S. Dorn-Kling andJ.M. Gokel,Immunosuppressive therapy in liver and small bowel grafts in the rat, Z. Kinderchir.30, 177–180 (1980).
A. Zschauer andCh. Hodel,Drug-induced changes in rat seminiferous tubular epithelium, Arch. Toxicol. Suppl.4, 466–470 (1980).
Author information
Authors and Affiliations
Additional information
To whom correspondence and reprint requests should be addressed.
Rights and permissions
About this article
Cite this article
Thomson, A.W., Whiting, P.H. & Simpson, J.G. Cyclosporine: Immunology, toxicity and pharmacology in experimental animals. Agents and Actions 15, 306–327 (1984). https://doi.org/10.1007/BF01972366
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01972366